Neurochemistry International 1991: Vol 18 Index

10 Pages·1991·2.9 MB·English

AUTHOR INDEX
Abou-Donia M. B. 191 Edelman G. M. 97 Johnson B. G. 41]
Agnati L. F. 347 Edvinsson L. 571 Johnston G. A. R. 63
Aguilar J. S. 39 Enomoto R. 55 Johns A. 575
Aimoto S. 525 Eta E. 559 Jones C. R. 507
Akiyama H. 535 Jordan S. J. 373
Alafuzoff I. 389, 399 Fanger B. O. 185 Joubert R. 275
Albrecht J. 125 Ferraguti F. 347
Aldegunde M. 199 Fonseca M. I. 39 Kadowitz P. J. 547
Allan R. D. 63 Fosbraey P. 265 Kamio Y. 257
Aumelas A. 471 Fowler C. J. 389 Kashiwabara T. 535
French M. C. 265 Kataoka Y. 503
Friedman M. 191 Kato H. 257
de Backer J. P. 137
Fuxe K. 347 Kato T. 257
Balcar V. J. 43
Kishikawa T. 257
Barraco R. A. 243
Garcia-Peregrin E. 171 Kitamura Y. 331
Barry R. 291
Garlind A. 389 Knapp R. J. 405
Basset P. 131
Gautron J.-P. 221 Kobayashi Y. 525
Bauer K. 221
Ghosh J. J. 107 Koizumi S. 503
Beart P. M. 75
Bergstrom L. 399 Giachetti A. 565 Kondo T. 525
van Giersbergen P. L. M. 167 Kordon C. 221
Berthault P. 471
Giroux M. L. 405 Koshiya N. 519
Bettuzzi S. 347
Giuliani S. 565 Kouda T. 55
Bladier D. 275
Goswami S. 107 Kuhn D. M. 33
Blanco I. 237
Goudou D. 97 Kumada M. 519
Blondet B. 425
Gozlan H. | Kuwaki T. 519
Boichot E. 477
Grahame-Smith D. G. 69 K yogoku Y. 525
Bortmann P. 491
Braquet P. 477, 481 Groome N. 291
Guard S. 149 La M. 465
Brisac A.-M. 553
Lagente V. 477, 481
Bucher B. 455
Hallén A. 515 Lapadula D. M. 191
Buck S. H. 167
Hamano S. 283 Laporte A.-M. |
Burcher E. 167
Hamon M. | Le Caer J. P. 275
Hardy J. 373 Lecci A. 565
Cardell L. O. 571 Harvey J. M. 69 Le-Nguyen D. 471
Caron M. 275 Heim C. 175 Leslie R. A. 69
Carrington C. D. 191 Hemsén A. 515 Levi de Stein M. 39
Castillo M. 171 Higashida H. 419 Lieu A. T. 461
Champeroux P. 553 Hiley C. R. 445 Liu X. 27
Cheng H. C. 497 Hoflack J. 491 Louis J.C. 131
Chiche L. 471 Hojo H. 525 Lucacchini A. 51
Cincotta M. 75 Hoyer D. 17 Lundberg J. M. 515
Collier B. 115 Hu S. 541 Lynch M. 373
Collins M. J. 439
Humbert T. 367
Commissiong J. W. 249 Maggi C. A. 565
Corti A. 347 Iglesias J. 171 Magistretti P. J. 303
Cowburn R. F. 389 Ikeda M. 405 Magnier A. 553
Ikenaka K. 525 Mahe E. 471
Dage R. C. 497 Imai S. 331 Malatynska E. 405
Dashwood M. R. 439 Imazawa M. 357 Markefski M. 323
Daval G. 1 Inagaki Y. 535 Martel E. 553
De Robertis E. 39 Ingletti M. C. 347 Martin F. 199
Devesly P. 575 Ito J. 257 Martini C. 51
Dickenson H. W. 63 Iwamatsu A. 535 Mége R.-M. 97
Dilsaver S. C. 405 Melki J. 425
Douglas S. A. 445 Jacobson K. A. 207 Mencia-Huerta J.-M. 477, 481
Dreyfus P. 425 Jefferys J. G. R. 373 Mengod G. 17
Duke R. K. 63 Jeng A. Y. 541 Mercer L. D. 75
Dulak L. 191 Ji X.-D. 207 Mikoshiba K. 525
Index
Miller K. 85 Rand M. J. 465 Tassin A.-M. 97
Minkes R. K. 547 Reid J. J. 461 Tenenhouse A. 249
Mitchell P. 373 Revel M. O. 131 Teo W. L. 353
Miyamoto K. 357 Rewers-Felkins K. 575 Teraoka K. 283
Morgan R. C. 75 Reynolds D. J. M. 69 Terui N. 519
Morita A. 535 Richard S. 553 Theodoropoulos S. 439
Morita K. 283 Richards M. H. 507 Tiley C. 373
Moroder L. 525 Rieger F. 97, 425 Toda T. 257
Mulder A. H. 215 Rodriguez J. 237 Toledo A. 237
Rodriguez R. 237 Touvay C. 477, 481
Nabeshima T. 55 Rosenthal L. P. 115 Triggle C. R. 559
Nakajima K. 357 Rossier J. 275
Nilsson L. 399 Rovero P. 565 Uddman R. 571
Nishikori K. 535 Rubanyi G. M. 575 Ueki S. 503
Nishimura S. 525
Niwa M. 503 Vauquelin G. 137
Sabria J. 237
Nomizu M. 535 Verge D. |
Safar M. 553
Nomura Y. 331 Vieira R. 199
Sakai T. 419
Norenberg M. D. 125 Vincendon G. 131
Sasaki S. 257
Nozawa Y. 419 Volkmann I. 399
Sato A. 525
de Vos H. 137
Sattelle D. B. 341
Ogita K. 55 Vrana K. E. 27
Saudek V. 491
O’Hara L. 373
Savage P. 541
Ohkawara A. 55 Wade A. C. 185
Scates P. W. 381
Ohta H. 535 Wadsworth J. 373
Schaad N. C. 303
Oka M. 283 Waeber C. 17
Scheer H. W. 115
Okano Y. 419 Walter G. A. 243
Schoepp D. D. 411
O'Neill C. 389 Warner M. 249
Schorderet M. 303
Osborne N. N. 175 Watson S. P. 149
Sepulveda M.-I. 341
Wetherell J. R. 265
Sharif N. A. 89
Pacini R. 51 White H. L. 381
Sieklucka M. 175
Palacios J. M. 17 Whiting R. L. 89
Singh I. S. 107
Parker-Botelho L. H. 575 Winblad B. 389, 399
Sizun P. 471
Pattou E. 221 Wolf G. 323
Smits R. P. J. M. 215
Paya D. 455 Wolf W. A. 33
Sontag K. H. 175
Payton M. 291 Wong P. T.-H. 353
Stiles G. L. 207
Pelton J. T. 485, 491 Wong-Dusting H. K. 465
Stoclet J.-C. 455
Perly B. 471
Stoeckel M. E. 507
Pernow J. 515 Yacoub M. H. 439
Suzuki T. 55
Phillis J. W. 243 Yamamura H. I. 405
Sykes R. M. 439
Pingon-Raymond M. 425 Yamashita K. 507
Poduslo S. E. 85 Yoneda Y. 55
Polasek P. M. 243 Takashima H. 525
Pons F. 477, 481 Tamaoki H. 525 Zafra M. F. 171
Prehar S. 439 Tanaka R. 257 Zini I. 347
Tao F. 419 Zoli M. 347
Radja F. | Tapia-Arancibia L. 367 Zwiller J. 131
SUBJECT INDEX
acetylcholine release - effect of various substances, 115
acetylcholine release - from synaptosomes, 115
acetylcholinesterase activity - reduced in Wobbler mutant mouse,
425
acetylcholinesterase - content in the CNS, 265
14C-acrylamide - binding to CNS, 191
A,-adenosine receptor - xanthine amine congener is a ligand, 207
S-adenosyl methionine - effect on a,-receptors, 39
adenylyl cyclase activity - characterization and distribution,
389
adenylyl cyclase activity - in human brain, 389
a,-adrenoreceptors - effect of S-adenosyl methionine, 39
a,-adrenoceptor antagonist - Efaroxan, 137
aluminium chloride - effect on release of taurine and GABA, 125
2-amino-3-phosphonopropionic acid - inhibits metabotrophic
excitatory amino acids, 411
ammonia influence on NAD(P)H, 323
3H-AMPA binding to synaptic membranes, 75
3H-AMPA lack of effect of barbiturates on binding, 75
3H-AMPA = [3H]a-amino-3-hydroxy-5-methylisoxazole-4-propionic acid
anoxic stress - effect of diazepam treatment, 107
apamin - neurotoxin mast cell degranulating peptide, 525
arachidonic acid - effect on guanylate cyclase, 131
aromatic acid decarboxylases, 27
astrocytes - release of GABA and taurine, 125
ATP - cytoplasmic levels, 283
ATP - influence on catecholamine synthesis, 283
autoradiography of 5-HT receptors, 17
autoradiography of 5-HT, receptors, 69
autoradiography of serotonin receptors, 1
autoradiography - of !125I-endothelin binding, 439
barbiturates - lack of effects on 3H-AMPA binding, 75
benzodiazepine antagonist - Ro15-1788, 405
benzodiazepine antagonist - interaction with GABA, 405
Big-endothelin-1 - bronchopulmonary and pressor effects, 481
binding sites - of *H-tryptophan, 347
binding - of 5-HT ligands, 331
binding - of endothelin to various tissues of hypertensive rats,
541
binding of endothelin-1, 507
binding of !25I-Bolton Hunter substance P, 399
binding of 14C-acrylamide to CNS, 191
binding of *H-endothelin to coronary tissue, 439
binding - of 3?H-glutamate, 341
binding - of 3?H-xanthine amine congener, 207
125[T-Bolton Hunter substance P binding sites - in human brain,
399
B,-bradykinin receptors - in CNS and peripheral tissues, 89
bradykinin - stimulates phosphoinositide turnover, 419
bronchopulmonary effects - by Big-endothelin-1, 481
bronchopulmonary response - effect of endothelin-1 and
phosphoramidon, 477
2,3-butanedione inactivates binding of [35s]t-
butylbicylophosphorothionate, 51
[35S]t-butylbicylophosphorothionate - binding inactivated by
2,3-butanedione, 51
calcium fluxes - by endothelin-2, 575
calcium mobilization - by endothelin-2, 575
calcium - intracellular levels in synaptosomes, 115
[3H] (+)-3-(2-carboxypiperazin-4-YL) propyl-1-phosphonate - effect
of SH-reactive agents on binding, 55
carotid arteries - occlusion, 175
catecholamine synthesis - in adrenal chromaffin cells, 283
catecholamine synthesis - influence of ATP, 283
cerebrospinal fluid - myelin basic products, 291
cerebrospinal fluid - purine levels, 243
charybdotoxin - neurotoxin mast cell degranulating peptide, 525
chloride uptake - effect of GABA and Ro15-1788, 405
cholesterogenic enzymes, 171
chromaffin cells - catecholamine synthesis, 283
cocaine - and serotonin, 33
cocaine - serotonin uptake, 33
coiled coils - in aromatic acid decarboxylases, 27
damselfly - metabolism of 5-HT, 199
diabetic rat - effect of endothelin-1 an atria, 461
diazapam - effect on GABAergic system, 107
diazepam treatment - effect of anoxic stress, 107
dihydropyridine-sensitive calcium channels - activation induces
somatostatin release, 367
down-regulation - of protein kinase C, 419
Efaroxan - selective a,-antagonist, 137
eicosanoids - role in CNS, 303
endocytosis - cis-platinum-encapsulating liposome, 257
Index
125T-endothelin binding sites - to human coronary tissue, 439
endothelin binding - to various tissues from hypertensive rats,
541
endothelin receptors - two types in arteries, 571
endothelin (16-21) - effect on blood pressure and micturition
reflex, 565
endothelin - a neurotoxic factor, 503
endothelin - effect on vascular and non-vascular smooth muscle,
559
endothelin - formation, release, 515
endothelin - involvement of hypoglycemic/ischemic brain injury,
503
endothelin - neurotoxin mast cell degranulating peptide, 525
endothelins - effect on cardiovascular and pulmonary responses,
547
endothelin-1 - binding sites and stimulation of inositol
monophosphates, 507
endothelin-1 - effect of intravenous perfusion, 445
endothelin-1 - effect on atria from diabetic rat, 461
endothelin-1 effect on blood pressure and micturition reflex,
565
endothelin-1 - effect on ear arteries, 465
endothelin-1 - fluorescent studies, 485
endothelin-1 - in pressor response, 553
endothelin-1 modulates cardiorespiratory control of the CNS,
519
endothelin-1 modulates 3H-noradrenaline release, 455
endothelin-1 potentiates the effect of phosphoramidon, 477
endothelin-1 receptor binding, 535
endothelin-2 - mobilization of intracellular calcium and
stimulation of calcium fluxes, 575
endothelin-3 - effect on »lood pressure and micturition reflex,
565
endothelin-3 - 'H NMR studies, 491
endothelin-like peptides, 515
endothelium-denuded arteries - effect of endothelin-1, 465
endothelium-intact arteries - effect of endothelin-1, 465
N-ethylmaleimide - effect on 5-HT receptors, 331
excitatory amino acid agonists - effect on phosphoinositide
hydrolysis, 411
fluorescent studies - of endothelin-1, 485
GABA release - effect of aluminium chloride, 125
GABA release - from astrocytes, 125
GABA release - from TTX-induced chronic epileptic foci, 373
GABA release - in seizures, 373
GABA uptake - ZAPA a substrate, 63
GABA - ex vivo release, 373
GABA - interaction with benzodiazepine, 405
GABAergic system - effect of diazepam, 107
GABA, receptor, 405
B-galactoside - amino acid sequence, 275
B-galactoside - lectin in brain, 275
gastrin - competes with somatostatin for binding to 120 kDa
protein, 185
3H-glutamate binding - to insect muscle membranes, 341
3H-glutamate binding - to synaptic membranes, 55
3H-glutamate -effect of SH-reactive agents on binding, 55
glutamate uptake - ionic requirements, 43
glutamate - uptake, 43
GTPYS - effect on phosphoinositide metabolism, 381
guanylate cyclase - effects of arachidonic acid and
hydroperoxides, 131
G-proteins - associated with neurokinin receptors, 158
hippocampal slices - effect of neurotoxins, 323
hippocampus - neurotransmitter levels, 268
histamine - effect on noradrenaline release, 215
histamine - effect on ornithine decarboxylase activity, 237
histamine - effect on serotonin release, 215
hydroperoxides - effect on guanylate cyclase, 131
5-hydroxytryptamine receptor subtypes, 331
5-hydroxytryptamine receptors - effect of N-ethylmaleimide, 331
S-hydroxytryptamine - metabolism in damselfly, 199
5-HT, see also serotonin
5-HT receptors - autoradiography, 17
S-HT,, receptors, 2
5-HT,, receptors, 3
S-HT,,< receptors, 4
5-HT,,) receptors, 6
5-HT, receptors - different types, 17
5-HT, receptors, 8
5-HT, receptors, 9
5-HT, receptors - autoradiographic localisation, 69
hyperketonemia - lipid synthesis, 85
hypertensive rats - effect of endothelin-1, 553
hyperthyroidism - lipid synthesis, 85
hypocalcemic rat, 249
hypoglycemic injury - involvement of endothelin, 503
hypoxia - effect on CSF levels of purines, 243
Index
hypoxic conditions - effect on NAD(P)H, 323
in situ hybridization - of ornithine decarboxylase, 347
inositol monophosphates - stimulation by endothelin-1, 507
inositol phosphates - and a,-receptors, 175
inositol phosphates - effect of carotid artery occlusion, 175
insect muscle - binding of *H-glutamate, 341
ionic requirements - in glutamate uptake, 43
ischemic injury - involvement of endothelin, 503
ketone bodies - precursors for lipid synthesis, 85
ketone bodies - used in brain during development, 85
lanthanides - effect on acetylcholine release and intracellular
calcium levels, 115
a-latrotoxin - effect on acetylcholine release and intracellular
calcium levels, 115
lectin - B-galactoside, 275
leucine zippers - in aromatic amino acid decarboxylase, 27
lipid synthesis - from ketone bodies, 85
luteinizing hormone-releasing hormone-like material - in frog
CNS, 221
metabotrophic axcitatory amino acid receptors - inhibited by 2-
amino-3-phosphonopropionic acid, 411
Multiple Sclerosis - myelin basic protein products in CSF, 291
muscle - effect of endothelin and sarafotoxin, 559
myelin basic protein catabolism, 291
myelin basic protein - catabolism, 291
myelin basic protein - in chick brain, 357
myelin - from chick, 357
myogenesis - distribution of N-CAM, 97
NAD(P)H - influence of ammonia, octanoate, quinolinate and
hypoxia, 323
NCB-20 cells - down regulation of protein kinase C, 419
neuroblastoma cells, 257
neurokinin receptors, 152
neurotoxic factor - endothelin, 503
neurotoxin mast cell degranulating peptides, 525
neurotoxins - effect on hippocampal slices, 323
neurotransmitter levels - in hippocampus and striatum, 268
neurotransmitters - in vitamin D deficient hypocalcemic rat, 249
'H NMR - of endothelin-3, 491
"H NMR - studies on structure of sarafotoxin-S6b, 471
noradrenaline release - effect of histamine, 215
3H-noradrenaline release - modulated by endothelin-1, 455
normotensive rats - effect of endothelin-1, 553
nucleotides - effect on phosphoinositides, 381
N-CAM expression - modulation, 97
N-CAM - absent in Wobbler mutant mouse, 425
N-CAM - distribution during myogenesis, 97
octanoate - influence on NAD(P)H, 323
ornithine decarboxylase activity - effect of histamine, 237
ornithine decarboxylase mRNA levels, 347
ornithine decarboxylase mRNA levels - in situ hybridization, 347
phenolic derivatives - of phenylalanine, 171
phenylalanine - phenolic derivatives, 171
Phenylketonuria, 171
phorbol esters - effect on protein kinase C, 419
phosphoinositide hydrolysis - effect of excitatory amino acids,
411
phosphoinositide metabolism - effect of GTPXs and nucleotides,
381
phosphoinositide metabolism - in synaptosomes, 381
phosphoinositide pathway - with neurokinin receptors, 158
phosphoinositide turnover - by bradykinin, 419
phosphoramidon - effect on endothelin-1 response, 477
physostigmine-hyoscine pretreatment - neurochemical changes, 265
cis-platinum-encapsulating liposome - uptake by endocytosis in
neuroblastoma cells, 257
potassium - effect on acetylcholine release and intracellular
calcium levels, 115
pressor effects - by Big-endothelin-1, 481
pressor response - to endothelin-1, 553
proendothelin (1-38) - from humans, 445
proendothelin (1-39) - from porcine, 445
prostaglandins - role in CNS, 303
prostanoids - role in cell-cell interactions, 303
protein kinase C - down regulation, 419
purine concentrations - in CSF after hypoxia, 243
quinolinate - influence on NAD(P)H, 323
receptor binding - of endothelins, 535
receptor types - neurokinin, 152
receptor types - tachykinins, 149
a,-receptors - and inositol phosphates, 175
receptors - A,-adenosine type, 207
receptors - serotonin subtypes, 1
receptors - tachykinins, 167
mRNA levels - of ornithine decarboxylase, 347
Ro15-1788 - a benzodiazepine antagonist, 405
sarafotoxin 6b - effect on cardiovascular and pulmonary
responses, 547
Index
sarafotoxin - effect on vascular and non-vascular smooth muscle,
559
sarafotoxin-S6b - 'H NMR studies, 471
seizure - release of GABA, 373
serotonin, see also 5-HT or 5-hydroxytryptamine
serotonin receptors - autoradiography, 1
serotonin receptors - different subtypes, 1
serotonin release - effect of histamine, 215
serotonin uptake - effect of cocaine, 33
serotonin - and cocaine, 33
SH-reactive agents - effect on binding of [3H]/{+)-3-(2-
carboxypiperazin-4-YL) propyl-1-phosphonate, 55
SH-reactive agents - effect on *H-glutamate binding, 55
signalling mechanisms - involvement of tachykinins, 149
soman intoxication, 265
soman - production of neurochemical changes, 265
somatostatin release - involvement of dihydropyridine-sensitive
calcium channels, 367
somatostatin - competes with gastrin for binding to 120 kDa
protein, 185
striatum - neurotransmitter levels, 270
stroke - myelin basic protein products in CSF, 291
substance P - binding sites, 399
synaptosomes - intracellular calcium levels, 115
Synaptosomes - phosphoinositide metabolism, 381
tachykinins - receptor subtypes, 149
tachykinins - receptors, 167
taurine release - effect of aluminium chloride, 125
taurine release - from astrocytes, 125
Tetanus toxin-induced chronic epileptic foci - release of GABA,
373
3H-tryptophan - binding sites in brain, 347
uptake - of glutamate, 43
vitamin D deficient hypocalcemic rat - effect on
neurotransmitters, 249
Wobbler mutant mouse - reduced acetylcholinesterase and lack of
N-CAM, 425
3H-xanthine amine congener - binding, 207
xanthine amine congener - radioligand for A,-adenosine receptor,
207
ZAPA - substrate for GABA uptake, 63
ZAPA = Z-3[(aminoiminomethyl)thio]prop-2-enoic acid
(hydroxyproline? )luteinizing hormone-releasing hormone
a novel peptide, 221